Roche Crp T Control N
C-Reactive Protein, Antigen, Antiserum, And Control. 510(k) K982087, from Roche Diagnostic Systems, Inc. (Somerville, NJ). Product code DCK, class 2.
As of Nov 20, 2026, K982087 is an FDA 510(k) held by Roche Diagnostic Systems, Inc., substantially equivalent on Aug 18, 1998 after 64 days, with no recalls tied to it in FDA's recall database.
- Review time: 64 days
- Recalls: 0
- Cited as a predicate by: 1 device
Roche CRP T Control N is an assayed control intended for use to monitor the accuracy and precision at normal concentraion levels in quantitative C-reactive protein (CRP) assays. It is recommended for use with Roche reagents on COBAS® chemistry systems.
- N/T Rheumatology Control SL/1 and SL/2K962373 · Behring Diagnostics, Inc. · Jul 11, 1996
- Crpex Crp Controls Level L, M, H; Cat. No.: 3011, 3012, 3013K022725 · Good Biotech Corp. · Sep 23, 2002
- K-ASSAY CRP (Ver.2)K242170 · Kamiya Biomedical Company, LLC · Apr 18, 2025
- Procise CRP, ProciseDx Analyzer, ProciseDx Calibration CartridgeK201256 · Procise Diagnostics · Nov 4, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 15, 1998
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5270
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files